Nuclear factor erythroid 2-related factor 2 nuclear translocation induces myofibroblastic dedifferentiation in idiopathic pulmonary fibrosis

Antioxidants and Redox Signaling

Volumn 18, Issue 1, 2013, Pages 66-79

  Artaud Macari, Elise ^a   Goven, Delphine ^a   Brayer, Stéphanie ^a   Hamimi, Akila ^a   Besnard, Valérie ^a   Marchal Somme, Joëlle ^a   Ali, Zeina El ^a   Crestani, Bruno ^a,b   Kerdine Römer, Saadia ^a   Boutten, Anne ^a,b   Bonay, Marcel ^a,b,c,d  

^a INSERM   (France)

^b BICHAT HOSPITAL   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d University of Versailles Saint Quentin en Yvelines   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; BLEOMYCIN; COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA1; EPOXIDE HYDROLASE; HEME OXYGENASE 1; PLATELET DERIVED GROWTH FACTOR BB; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE QUINONE OXIDOREDUCTASE 1; SMALL INTERFERING RNA; SULFORAPHANE; TRANSCRIPTION FACTOR NRF2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DEDIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; FIBROBLAST; FIBROGENESIS; FIBROSING ALVEOLITIS; GENE EXPRESSION REGULATION; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION;

ACTIVE TRANSPORT, CELL NUCLEUS; ALDEHYDES; ANIMALS; CELL DEDIFFERENTIATION; CELL NUCLEUS; CELLS, CULTURED; COLLAGEN TYPE I; EPOXIDE HYDROLASES; GENE KNOCKDOWN TECHNIQUES; HEME OXYGENASE-1; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; LIPID PEROXIDATION; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOFIBROBLASTS; NAD(P)H DEHYDROGENASE (QUINONE); NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-SIS; RNA, SMALL INTERFERING; THIOCYANATES; TRANSFORMING GROWTH FACTOR BETA;

EID: 84870495496     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2011.4240     Document Type: Article

References (45)

1. Amara N, Goven D, Prost F, Muloway R, Crestani B, and Boczkowski J. NOX4/NADPH oxidase expression is increased in pulmonary fibroblasts from patients with idio-pathic pulmonary fibrosis and mediates TGFbeta1-induced fibroblast differentiation into myofibroblasts. Thorax 65: 733-738, 2010.
2. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664, 2000.
3. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165: 277-304, 2002.
4. Aono Y, Ledford JG, Mukherjee S, Ogawa H, Nishioka Y, Sone S, Beers MF, Noble PW, and Wright Jr. Surfactant protein-D regulates effector cell function and fibrotic lung remodeling in response to bleomycin injury. Am J Respir Crit Care Med 185: 525-536, 2012.
5. Blake DJ, Singh A, Kombairaju P, Malhotra D, Mariani TJ, Tuder RM, Gabrielson E, and Biswal S. Deletion of Keap1 in the lung attenuates acute cigarette smoke-induced oxidative stress and inflammation. Am J Respir Cell Mol Biol 42: 524-536, 2010.
6. Boutten A, Goven D, Artaud-Macari E, Boczkowski J, and Bonay M. NRF2 targeting: a promising therapeutic strategy in chronic obstructive pulmonary disease. Trends Mol Med 17: 363-371, 2011.
7. Cheung KL and Kong AN. Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer che-moprevention. Aaps J 12: 87-97, 2010.
8. Cho HY, Reddy SP, Yamamoto M, and Kleeberger SR. The transcription factor NRF2 protects against pulmonary fi-brosis. Faseb J 18: 1258-1260, 2004.
9. Dash PK, Zhao J, Orsi SA, Zhang M, and Moore AN. Sul-foraphane improves cognitive function administered following traumatic brain injury. Neurosci Lett 460: 103-107, 2009.
10. Dinkova-Kostova AT, Fahey JW, Wade KL, Jenkins SN, Shapiro TA, Fuchs EJ, Kerns ML, and TalalayP.Inductionofthe phase 2 response in mouse and human skin by sulforaphane-containing broccoli sprout extracts. Cancer Epidemiol Biomarkers Prev 16: 847-851, 2007.
11. Dinkova-Kostova AT, Holtzclaw WD, Cole RN, Itoh K, Wakabayashi N, Katoh Y, Yamamoto M, and Talalay P. Direct evidence that sulfhydryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes that protect against carcinogens and oxidants. Proc Natl Acad Sci USA 99: 11908-11913, 2002.
12. Fredenburgh LE, Perrella MA, and Mitsialis SA. The role of heme oxygenase-1 in pulmonary disease. Am J Respir Cell Mol Biol 36: 158-165, 2007.
13. Gan N, Wu YC, Brunet M, Garrido C, Chung FL, Dai C, and Mi L. Sulforaphane activates heat shock response and enhances proteasome activity through upregulation of HSP27. J Biol Chem 285: 35528-35536, 2010.
14. Gao X, Dinkova-Kostova AT, and Talalay P. Powerful and prolonged protection of human retinal pigment epithelial cells, keratinocytes, and mouse leukemia cells against oxidative damage: the indirect antioxidant effects of sulforaphane. Proc Natl Acad Sci USA 98: 15221-15226, 2001.
15. Goven D, Boutten A, Lecon-Malas V, Boczkowski J, and Bonay M. Prolonged cigarette smoke exposure decreases heme oxygenase-1 and alters Nrf2 and Bach1 expression in human macrophages: roles of the MAP kinases ERK(1/2) and JNK. FEBS Lett 583: 3508-3518, 2009.
16. Goven D, Boutten A, Lecon-Malas V, Marchal-Somme J, Soler P, Boczkowski J, and Bonay M. Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneu-mothorax: role of HIF-1alpha. PLoS One 5: e10886, 2010.
17. Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ, and Thannickal VJ. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med 15: 1077-1081, 2009.
18. Huet E, Vallee B, Szul D, Verrecchia F, Mourah S, Jester JV, Hoang-Xuan T, Menashi S, and Gabison EE. Extracellular matrix metalloproteinase inducer/CD147 promotes myofi-broblast differentiation by inducing alpha-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling. FASEB J 22: 1144-1154, 2008.
19. Itoh K, Chiba T, Takahashi S, Ishii T, Igarashi K, Katoh Y, Oyake T, Hayashi N, Satoh K, Hatayama I, Yamamoto M, and Nabeshima Y. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun 236: 313-322, 1997.
20. Kensler TW, Wakabayashi N, and Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 47: 89-116, 2007.
21. Keum YS, Yu S, Chang PP, Yuan X, Kim JH, Xu C, Han J, Agarwal A, and Kong AN. Mechanism of action of sulfor-aphane: inhibition of p38 mitogen-activated protein kinase isoforms contributing to the induction of antioxidant response element-mediated heme oxygenase-1 in human hepatoma HepG2 cells. Cancer Res 66: 8804-8813, 2006.
22. Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K, Yamamoto M, and Hizawa N. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 11: 31, 2010.
23. Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Yamadori T, Masuko H, Sakamoto T, Yanagawa T, Warabi E, Ishii T, and Hizawa N. Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking perox-iredoxin I. Am J Respir Cell Mol Biol 45: 600-609, 2011.
24. King TE, Jr. and Pardo A, and Selman M. Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961, 2011.
25. Kinnula VL and Myllarniemi M. Oxidant-antioxidant imbalance as a potential contributor to the progression of human pulmonary fibrosis. Antioxid Redox Signal 10: 727-738, 2008.
26. Kirkham P and Rahman I. Oxidative stress in asthma and COPD: antioxidants as a therapeutic strategy. Pharmacol Ther 111: 476-494, 2006.
27. Lakari E, Pylkas P, Pietarinen-Runtti P, Paakko P, Soini Y, and Kinnula VL. Expression and regulation of hemeox-ygenase 1 in healthy human lung and interstitial lung disorders. Hum Pathol 32: 1257-1263, 2001.
28. Malhotra D, Portales-Casamar E, Singh A, Srivastava S, Arenillas D, Happel C, Shyr C, Wakabayashi N, Kensler TW, Wasserman WW, and Biswal S. Global mapping of binding sites for Nrf2 identifies novel targets in cell survival response through ChIP-Seq profiling and network analysis. Nucleic Acids Res 38: 5718-5734, 2010.
29. Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, Singh A, Chen L, Zhuang X, Hogg J, Pare P, Tuder RM, and Biswal S. Decline in NRF2-regulated antioxidants in chronic obstructive pulmonary disease lungs due to loss of its positive regulator, DJ-1. Am J Respir Crit Care Med 178: 592-604, 2008.
30. Markart P, Luboeinski T, Korfei M, Schmidt R, Wygrecka M, Mahavadi P, Mayer K, Wilhelm J, Seeger W, Guenther A, and Ruppert C. Alveolar oxidative stress is associated with elevated levels of nonenzymatic low-molecular-weight an-tioxidants in patients with different forms of chronic fi-brosing interstitial lung diseases. Antioxid Redox Signal 11: 227-240, 2009.
31. Mazur W, Lindholm P, Vuorinen K, Myllarniemi M, Sal-menkivi K, and Kinnula VL. Cell-specific elevation of NRF2 and sulfiredoxin-1 as markers of oxidative stress in the lungs of idiopathic pulmonary fibrosis and non-specific interstitial pneumonia. Apmis 118: 703-712, 2010.
32. McWalter GK, Higgins LG, McLellan LI, Henderson CJ, Song L, Thornalley PJ, Itoh K, Yamamoto M, and Hayes JD. Transcriptionfactor Nrf2isessential for inductionofNAD(P)H: quinone oxidoreductase 1, glutathione S-transferases, and glutamate cysteineligaseby broccoli seeds and isothiocyanates. J Nutr 134: 3499S-3506S, 2004.
33. Nichols DP, Ziady AG, Shank SL, Eastman JF, and Davis PB. The triterpenoid CDDO limits inflammation in preclinical models of cystic fibrosis lung disease. Am J Physiol Lung Cell Mol Physiol 297: L828-L836, 2009.
34. Ning W, Song R, Li C, Park E, Mohsenin A, Choi AM, and Choi ME. TGF-beta1 stimulates HO-1 via the p38 mitogen-activated protein kinase in A549 pulmonary epithelial cells. Am J Physiol Lung Cell Mol Physiol 283: L1094-L1102, 2002.
35. Phan SH. The myofibroblast in pulmonary fibrosis. Chest 122: 286S-289S, 2002.
36. Qazi A, Pal J, Maitah M, Fulciniti M, Pelluru D, Nanjappa P, Lee S, Batchu RB, Prasad M, Bryant CS, Rajput S, Gryaznov S, Beer DG, Weaver DW, Munshi NC, Goyal RK, and Shammas MA. Anticancer activity of a broccoli derivative, sulforaphane, in barrett adenocarcinoma: potential use in chemoprevention and as adjuvant in chemotherapy. Transl Oncol 3: 389-399, 2010.
37. Rachakonda G, Sekhar KR, Jowhar D, Samson PC, Wikswo JP, Beauchamp RD, Datta PK, and Freeman ML. Increased cell migration and plasticity in Nrf2-deficient cancer cell lines. Oncogene 29: 3703-3714, 2010.
38. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flaherty KR, Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE, Jr., Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, and Schunemann HJ. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824, 2011.
39. Sekharam M, Trotti A, Cunnick JM, and Wu J. Suppression of fibroblast cell cycle progression in G1 phase by N-acetylcysteine. Toxicol Appl Pharmacol 149: 210-216, 1998.
40. Shin DH, Park HM, Jung KA, Choi HG, Kim JA, Kim DD, Kim SG, Kang KW, Ku SK, Kensler TW, and Kwak MK. The NRF2-heme oxygenase-1 system modulates cyclosporin A-induced epithelial-mesenchymal transition and renal fibro-sis. Free Radic Biol Med 48: 1051-1063, 2010.
41. Sriram N, Kalayarasan S, and Sudhandiran G. Epigalloca-techin-3-gallate augments antioxidant activities and inhibits inflammation during bleomycin-induced experimental pulmonary fibrosis through Nrf2-Keap1 signaling. Pulm Pharmacol Ther 22: 221-236, 2009.
42. Sugiura H, Ichikawa T, Liu X, Kobayashi T, Wang XQ, Kawasaki S, Togo S, Kamio K, Mao L, Ann Y, Ichinose M, and Rennard SI. N-acetyl-L-cysteine inhibits TGF-beta1-induced profibrotic responses in fibroblasts. Pulm Pharmacol Ther 22: 487-491, 2009.
43. Travis EL, Rachakonda G, Zhou X, Korhonen K, Sekhar KR, Biswas S, and Freeman ML. NRF2 deficiency reduces life span of mice administered thoracic irradiation. Free Radic Biol Med 51: 1175-1183, 2011.
44. Yamaji-Kegan K, Su Q, Angelini DJ, Champion HC, and Johns RA. Hypoxia-induced mitogenic factor has proangio-genic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol 291: L1159-L1168, 2006.
45. Zhu H, Jia Z, Strobl JS, Ehrich M, Misra HP, and Li Y. Potent induction of total cellular and mitochondrial anti-oxidants and phase 2 enzymes by cruciferous sulforaphane in rat aortic smooth muscle cells: cytoprotection against oxidative and electrophilic stress. Cardiovasc Toxicol 8: 115-125, 2008.